NCT00501306 Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men Status COMPLETED Phase N/A
NCT00500006 A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) Status TERMINATED Phase PHASE1
NCT00496626 An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00496353 MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) Status COMPLETED Phase PHASE1/PHASE2
NCT00496327 Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) Status COMPLETED Phase PHASE3
NCT00496093 Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) Status COMPLETED Phase PHASE3
NCT00496054 Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) Status COMPLETED Phase PHASE3
NCT00495651 Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) Status COMPLETED Phase PHASE3
NCT00493805 Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303) Status TERMINATED Phase PHASE4
NCT00491764 A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00489099 A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) Status COMPLETED Phase PHASE3
NCT00488774 An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis Status TERMINATED Phase PHASE2/PHASE3
NCT00488631 An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00487539 An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2/PHASE3
NCT00486720 Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064) Status TERMINATED Phase PHASE2
NCT00485758 Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) Status COMPLETED Phase PHASE3
NCT00483704 Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031) Status COMPLETED Phase PHASE3